Systematic review and meta-analysis shows remimazolam versus non-remimazolam anesthesia and delirium risk
New Anesthesia Drug Does Not Raise Delirium Risk After Surgery
This systematic review and meta-analysis evaluates remimazolam compared with non-remimazolam agents in surgical patients. The analysis inclu…
A new anesthetic called remimazolam does not raise the risk of confusion after surgery, and it may protect children from waking up agitated.
Remimazolam shows comparable sedation success and better hemodynamic stability versus propofol in fiberoptic bronchoscopy
Remimazolam keeps breathing steadier during bronchoscopy than propofol
This retrospective analysis compared remimazolam and propofol in patients undergoing fiberoptic bronchoscopy with preserved spontaneous brea…
Remimazolam matched propofol’s success during bronchoscopy while cutting low oxygen, injection pain, and low blood pressure.
Narrative review on remimazolam reversal with flumazenil versus propofol sedation
New Sedation Reversal Method Cuts Recovery Time by 4 Minutes
This narrative review synthesizes evidence on flumazenil reversal of remimazolam-induced sedation compared to propofol-based sedation.
A new sedation reversal method helps patients wake up four minutes faster after procedures while reducing breathing and blood pressure issue…